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Laparoscopic nephroureterectomy (LNU) is becoming an increasingly common alternative treatment for transitional cell
carcinoma (TCC) of the renal pelvis and ureter due to decreased perioperative morbidity, shorter hospitalization, and comparable
oncologic control with open nephroureterectomy (ONU). Mobilization of the kidney and proximal ureter may be performed
through a transperitoneal, retroperitoneal, or hand-assisted approach. Each technique is associated with its own beneﬁts and
limitations, and the optimal approach is often dictated by surgeon preference. Our analysis of the literature reﬂects equivalent
cancer control between LPN and OPN at intermediate follow-up with signiﬁcantly improved perioperative morbidity following
LPN. Several methods for bladder cuﬀ excision have been advocated, however, no individual technique for management of the
distalureterprovedsuperior.Overall,completeen-blocresectionwithminimaldisruptionoftheurinarytractshouldbeoptimized
to maintain oncologic outcomes. Longer follow-up and prospective studies are needed to fully evaluate these techniques.
Copyright © 2009 Davis P. Viprakasit et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Transitional cell carcinoma (TCC) of the renal pelvis and
ureter is a disease associated with high propensity for tumor
recurrence and progression. Open radical nephroureterec-
tomy (ONU) with bladder cuﬀ excision is the traditional
standard treatment for most localized diseases of the upper
urinary tract because of its aggressive nature, as well as the
diﬃculty encountered with surveillance of the upper tract
urothelium [1]. To obtain adequate exposure, open excision
of the distal ureter and bladder cuﬀ requires either two skin
incisions or an extended ﬂank incision. This is associated
with increased perioperative morbidity and recovery time.
First described by Clayman et al. in 1991 [2], laparoscopic
radical nephroureterectomy (LNU) has shown signiﬁcant
advantages in terms of blood loss, postoperative pain and
recovery time, as well as comparable short and intermediate-
term oncologic outcomes with the open treatment [3]. As
more urologists are gaining increased comfort with mini-
mally invasive techniques, LNU exhibits a large growth in
worldwidepopularity[4].However,theoptimallaparoscopic
approachfornephroureterectomyaswellasthetechniquefor
addressing the bladder cuﬀ is unclear. We present a review
of the most recent literature detailing the perioperative and
cancer control outcomes observed with the various methods
of LNU and discuss the reported variations on bladder cuﬀ
excision.
2. Laparoscopic Nephroureterectomy
2.1. Approach. A variety of techniques have been utilized
to perform mobilization of the kidney and proximal ureter.
These include conventional transperitoneal, conventional
retroperitoneal, hand-assisted transperitoneal, and hand-
assisted retroperitoneal approaches. The choice of laparo-
scopic approach is most dependent on the comfort level
and training of the surgeon. However, each technique
has its own potential advantages. Transperitoneal exposure
oﬀers the largest working area and may be beneﬁcial for
e x t e n s i v et u m o r so rl y m p h a d e n o p a t h y .T h er e t r o p e r i t o n e a l
approach, however, involves decreased bowel manipulation
and potentially allows for earlier recovery of bowel function.
Additionally, this method may be favored in morbidly obese
patients with an obstructing pannus or in patients with2 Advances in Urology
a history of previous transperitoneal surgeries [5]. Hand-
assistance techniques allow for continued tactile sensation
and may lessen the learning curve required in laparoscopy
[6].MostoftheexperienceswithLNUareprimarilyreported
assingle-institutional retrospectiveseries. Todate, therehave
been no prospective randomized studies that compare the
diﬀerenttechniquesforLNU.However,datapublishedinthe
laparoscopic radical nephrectomy literature may be applica-
ble. For example, a randomized, prospective study compar-
ing conventional transperitoneal, retroperitoneal, and hand-
assisted transperitoneal laparoscopic radical nephrectomy
was recently published [7]. The hand-assisted technique
resulted in a signiﬁcantly shorter operative time but an
increased risk of hernia formation; conversely, conventional
transperitoneal surgery was associated with signiﬁcantly
improved perioperative morbidity. Desai et al. reported
shorter operative times and faster control of the renal
vasculature with retroperitoneal approaches in a prospective
randomizedcomparisonofconventionaltransperitonealand
retroperitoneal laparoscopic radical nephrectomy but no
signiﬁcant diﬀerences in other perioperative measures [5].
2.2. Perioperative Outcomes. Rassweiler et al. performed a
literature review of published studies between 1991 and 2004
of LNU and ONU, including nine comparative studies and
1365 overall patients [3]. As compared to ONU, LNU was
associated with a slightly longer operative time (277 versus
220 minutes), signiﬁcantly lower blood loss (241 versus
463mL), and shorter hospital stays, but showed similar
complication rates (18% versus 21%).
Table 1 summarizes the perioperative outcomes of 12
LNU studies published since 2005. The mean operating
time ranged from 165 to 395 minutes (mean 271) in the
laparoscopic group (n = 465 patients), and 155 to 313
minutes (mean 237) in the open group (n = 268 patients).
Signiﬁcantly increased operative time with laparoscopy was
noted in three of eight comparative studies, all of which
involved the retroperitoneal approach. The blood loss aver-
aged between 183 to 497mL (mean 279) in the laparoscopic
group as compared to a range of 296 to 558mL (mean
402) in the open group. Signiﬁcantly less blood loss after
laparoscopy was noted in four of eight comparative studies
with a similar trend in three of the remaining studies. The
overall complication rate ranged from 0 to 37% (mean 18%)
in the laparoscopy group and from 0 to 15% (mean 7%) in
the open group. The open conversion rate associated with
laparoscopy ranged from 0 to 10%. The absolute duration
of hospital stays varied between institutions. Out of eight
comparative studies, hospitalization following laparoscopy
wasshorterinsevenserieswithasigniﬁcantdiﬀerenceinﬁve.
2.3. Oncologic Outcomes. The highly aggressive natural his-
tory of upper tract TCC, particularly with high-grade and
high-stagedisease,likelycontributestoitsincreasedpotential
forrecurrenceandpoorprognosis irrespectiveofthesurgical
technique. However, there are many concerns that technical
aspects of LNU, particularly with regard to management of
the distal ureter and bladder cuﬀ,m a ya ﬀect recurrence risks
in the bladder, locally, or as port-site metastases secondary
to tumor seeding. Rassweiler et al. noted no signiﬁcant
diﬀerence in bladder recurrence (24% versus 25%), local
recurrence (4% versus 6%) and distant metastases (15.5%
versus 15.2%) in eight LNU series and 11 ONU series [3].
The 2-year cancer speciﬁc survival rates were also similar
(75% versus 76%).
Table 2 summarizestheshortandintermediateoncologic
outcomes of 14 LNU studies published since 2005. The most
common method for bladder cuﬀ excision was an open
approach. At a minimum median follow-up of at least 2
years, bladder recurrence after LNU (n = 488 patients)
ranged from 10 to 55% (mean 30%) as compared to 15 to
55% (mean 33%) in the ONU series (n = 512 patients).
Local recurrence in the retroperitoneum was documented as
0 to 13% (mean 3.3%) in the laparoscopic (n = 588 patients)
and 0 to 8% (mean 2.5%) in the open series (n = 512
patients). Distant metastases occurred in 0 to 18% (mean
9.5%) of patients undergoing LNU (n = 588 patients) as
compared to 5 to 35% (mean 14.5%) in the open series
(n = 512 patients). In six series reporting 2-year disease-
speciﬁc survival, the rates ranged from 64 to 91% (mean
83%) in the laparoscopic series (n = 274 patients) and
between 58 to 93% (mean 83.6%) after ONU (n = 242
patients). In the ﬁve series reporting 5-year survival rates,
the outcomes ranged from 68 to 90% (mean 85%) after
LNU (n = 202 patients) and 62 to 86% (mean 75%) in the
ONU groups (n = 191 patients). There was no signiﬁcant
diﬀerence between LNU and ONU survival rates in the
10 comparative studies. However, absolute comparisons
between the surgical approaches are diﬃcult as the percent-
age of patients with high-grade disease and the follow-up
period varied considerably, reﬂecting a large limitation with
the retrospective nature of these studies. In addition, the
inclusion of patients with a prior or concomitant history of
bladder cancer may aﬀect the oncologic outcome of treating
upper tract TCC. In the 14 LNU studies, only 7 addressed
this parameter in deﬁning their patient characteristics. The
4 comparative studies including such patients and the 1
study which excluded patients with bladder TCC did not
showasigniﬁcantdiﬀerencebetweenONUandLNUgroups.
However, it is unclear if the underlying biology and tumor
aggressiveness in patients with both upper and lower tract
TCC diﬀer from patients with isolated upper tract TCC;
inclusion of such patients in studies with already relatively
low numbers further complicates comparisons of treatment
approach.
2.4. Port-Site Metastases. One unique concern reported
following laparoscopic surgery is the occurrence of recurrent
malignant disease at the port-site [22]. To the best of
our knowledge, there have been 18 cases published in
the literature of port-site metastases of upper tract TCC
after laparoscopy (Table 3). In seven cases, the diagnosis of
TCC was not suspected preoperatively which inﬂuenced the
surgicaltechnique.Metastasesoccurred3to15monthspost-
operatively (mean 6.8). These overall experiences emphasize
that general preventive measures should be undertaken atAdvances in Urology 3
Table 1: Perioperative characteristics of LPN versus ONU cases. CR, conventional retroperitoneal; CT, conventional transperitoneal; HAT,
hand-assisted transperitoneal; NL, not listed; ONU, open nephroureterectomy.
Author Surgery Number
High
grade
(%)
OR
duration
(min)
Blood
loss
(min)
Conversion
(%)
Complication
(%) Hospital days
Muntener et al. [8] CT 39 31 (80) 312 300 4 (10) 12 (31) 4
Schatteman et al. [9] CT 100 48 (48) 192 234 7 (7) 19 (19) 10
Rouprˆ et et al. [10]
CT 20 8 (40) 165 275 1 (5) 3 (15) 4
ONU 26 19 (73) 155 338 — 4 (15) 9
Okegawa et al. [11]
CR 25 6 (24) 299 258 1 (4) 4 (16) 11
ONU 23 7 (30) 313 403 — 3 (13) 13
Tsujihata et al. [12]
CR 25 5 (20) 306 322 0 (0) 0 (0) 2
ONU 24 12 (50) 271 558 — 0 (0) 4
Taweemonkongsap et al. [13]
CR 31 13 (42) 259 289 0 (0) 2 (6) 9.3
ONU 29 19 (66) 191 314 — 2 (7) 8.7
Chung et al. [14]
HAT 39 16 (41) 233 183 0 (0) 5 (13) 7
ONU 36 15 (42) 220 422 — 3 (8) 9
Raman et al. [15]
HAT 38 15 (40) 244 191 0 (0) 4 (11) 5
ONU 52 19 (37) 243 478 — 2 (4) 7
Wolf et al. [16] HAT 53 26 (49) 279 330 1 (2) 20 (37) 4
Cannon et al. [17] HAT 34 NL 317 252 0 (0) 9 (26) 8
Chung et al. [18]
HAR 25 11 (44) 252 212 0 (0) 3 (12) 6.5
ONU 41 17 (41) 212 408 — 3 (7) 9
Nakashima et al. [19]
HAR 36 18 (50) 395 497 1 (3) 11 (31) 18.8
ONU 37 13 (35) 289 296 — 2 (5) 19.1
the conclusion of the surgery including the use of an
impermeable organ bag, minimal tissue handling, and the
avoidance of gross violation of the urinary system until the
specimen has been removed en bloc.
3. Bladder Cuff Excision
There is no consensus as to the optimal technique to
excise the distal ureter and ipsilateral bladder cuﬀ [1].
Deﬁnitive steps to minimize tumor seeding and complete
excision of the ureter are mandatory given the 30% to
64% tumor recurrence rate reported following inadequate
d i s t a lr e s e c t i o n s[ 31, 32]. As noted in Table 2, one of the
most utilized approaches involves an open approach. This
may be accomplished transvesically or extravesically via
a lower midline, Pfannenstiel, or Gibson incision, or by
incorporation of the hand port incision following hand-
assisted LNU. This technique is similarly employed during
ONU and oﬀers the surgeon familiarity, direct visualization,
and a simultaneous site for en bloc specimen extraction.
Awareness of the contralateral trigone and ureteral oriﬁce
location should be undertaken as potential injury may
occur during ipsilateral dissection or bladder cuﬀ closure
[33].
Alternatively, numerous endoscopic approaches have
been promoted. In 1952, McDonald et al. described the ﬁrst
endoscopic method of bladder cuﬀ excision, the “pluck”
technique, via transurethral resection of the ureteral oriﬁce
(TURUO) at the onset of surgery [34]. Resection of the
oriﬁce and intramural ureter, however, may require patient
repositioning and when performed at the onset of the pro-
cedure can expose the extravesical space to potential tumor
seeding. Several modiﬁcations have been described to this
technique in contemporary series, including delaying resec-
tion until after kidney mobilization, performing transvesical
endoscopy [35] or using transurethral cystoscopy with a
Bugbee electrode [36] or Collins knife for excision [37]. Ko
et al. reviewed their experience comparing open dissection
(n = 27 patients) with modiﬁed TURUO using a Collins
knife (n = 19 patients) following nephroureterectomy [38].
At a mean follow-up of over 22 months, they noted similar
bladder recurrence rates (22.2% versus 26.3%) without
evidence of pelvic recurrence.
The technique of ureteral intussusception has also been
described and involves endoscopic extraction of the ligated
ureter using a “stripping” method with the assistance of a
ureteral catheter [39]. However, this approach is contraindi-
cated with concomitant bladder or ureteral tumors and was
noted to have an incomplete excision rate of 18.7% in a large
single institutional series of 32 patients [40].
Gill et al. described the method of cystoscopic detach-
ment and ligation which incorporates intramural ureteral
dissection with a Collins knife aided by two transvesical
laparoscopic ports and an endoloop to ligate the ureteral
lumen and minimize potential tumor spillage [41]. While
this method most closely echoes the intentions of ONU, it4 Advances in Urology
T
a
b
l
e
2
:
O
n
c
o
l
o
g
i
c
o
u
t
c
o
m
e
s
o
f
L
P
N
v
e
r
s
u
s
O
N
U
c
a
s
e
s
.
C
R
,
c
o
n
v
e
n
t
i
o
n
a
l
r
e
t
r
o
p
e
r
i
t
o
n
e
a
l
;
C
T
,
c
o
n
v
e
n
t
i
o
n
a
l
t
r
a
n
s
p
e
r
i
t
o
n
e
a
l
;
H
A
R
,
h
a
n
d
-
a
s
s
i
s
t
e
d
r
e
t
r
o
p
e
r
i
t
o
n
e
a
l
;
H
A
T
,
h
a
n
d
-
a
s
s
i
s
t
e
d
t
r
a
n
s
p
e
r
i
t
o
n
e
a
l
;
L
N
D
,
l
y
m
p
h
n
o
d
e
d
i
s
s
e
c
t
i
o
n
;
L
S
,
l
a
p
a
r
o
s
c
o
p
i
c
s
t
a
p
l
i
n
g
;
N
L
,
n
o
t
l
i
s
t
e
d
;
O
N
U
,
o
p
e
n
n
e
p
h
r
o
u
r
e
t
e
r
e
c
t
o
m
y
;
S
D
,
s
u
r
g
e
o
n
d
i
s
c
r
e
t
i
o
n
;
T
U
R
U
O
,
t
r
a
n
s
u
r
e
t
h
r
a
l
r
e
s
e
c
t
i
o
n
;
T
V
,
t
r
a
n
s
v
e
s
i
c
a
l
.
A
u
t
h
o
r
S
u
r
g
e
r
y
N
F
o
l
l
o
w
u
p
(
m
o
)
H
i
s
t
o
r
y
o
f
b
l
a
d
d
e
r
t
u
m
o
r
s
p
e
c
i
ﬁ
e
d
B
l
a
d
d
e
r
c
u
ﬀ
s
u
r
g
e
r
y
P
a
t
h
s
t
a
g
e
(
T
a
,
T
i
s
,
T
1
/
T
2
,
T
3
,
T
4
)
P
a
t
h
g
r
a
d
e
(
1
/
2
/
3
)
L
N
D
U
r
o
t
h
e
l
i
a
l
r
e
c
u
r
r
e
n
c
e
(
%
)
L
o
c
a
l
r
e
c
u
r
r
e
n
c
e
(
%
)
P
o
r
t
-
s
i
t
e
r
e
c
u
r
r
e
n
c
e
(
%
)
D
i
s
t
a
l
r
e
c
u
r
r
e
n
c
e
(
%
)
D
i
s
e
a
s
e
-
s
p
e
c
i
ﬁ
c
s
u
r
v
i
v
a
l
(
@
y
e
a
r
)
M
u
n
t
e
n
e
r
e
t
a
l
.
[
8
]
C
T
3
9
7
4
Y
e
s
O
p
e
n
(
1
9
)
,
L
S
(
1
3
)
,
o
t
h
e
r
(
5
)
2
2
/
1
5
/
2
N
L
8
L
G
/
3
1
H
G
N
o
1
6
(
4
1
)
2
(
5
)
0
(
0
)
7
(
1
8
)
6
8
(
5
)
S
c
h
a
t
t
e
m
a
n
e
t
a
l
.
[
9
]
C
T
/
C
R
9
5
/
5
2
0
N
o
O
p
e
n
(
5
5
)
,
O
t
h
e
r
(
4
5
)
5
4
/
4
6
2
4
/
2
8
/
4
8
2
0
%
o
f
c
a
s
e
s
N
L
1
3
(
1
3
)
3
(
3
)
1
6
(
1
6
)
8
8
(
2
)
R
o
u
p
r
ˆ
e
t
e
t
a
l
.
[
1
0
]
C
T
2
0
6
9
N
o
O
p
e
n
1
5
/
5
1
1
/
1
5
1
2
L
G
/
8
H
G
S
D
2
(
1
0
)
0
(
0
)
0
(
0
)
2
(
1
0
)
9
0
(
5
)
O
N
U
2
6
7
8
7
L
G
/
1
9
H
G
4
(
1
5
)
0
(
0
)
9
(
3
5
)
6
2
(
5
)
O
k
e
g
a
w
a
e
t
a
l
.
[
1
1
]
C
R
2
5
2
4
Y
e
s
O
p
e
n
1
4
/
1
1
9
/
1
4
2
/
1
7
/
6
N
o
5
(
2
0
)
0
(
0
)
0
(
0
)
2
(
8
)
9
1
(
2
)
O
N
U
2
3
2
9
1
/
1
5
/
7
4
(
1
7
)
0
(
0
)
3
(
1
3
)
8
9
(
2
)
T
s
u
j
i
h
a
t
a
e
t
a
l
.
[
1
2
]
C
R
2
5
2
2
N
o
O
p
e
n
1
2
/
1
3
1
5
/
6
5
/
1
5
/
5
N
o
7
(
2
8
)
0
(
0
)
0
(
0
)
0
(
0
)
6
4
(
2
)
O
N
U
2
4
2
2
0
/
1
1
/
1
2
8
(
3
3
)
0
(
0
)
2
(
8
)
5
8
(
2
)
M
a
n
a
b
e
e
t
a
l
.
[
2
0
]
C
R
5
8
1
4
E
x
c
l
u
d
e
d
O
p
e
n
2
8
/
3
0
7
0
/
9
6
4
/
3
1
/
2
3
N
o
1
9
(
3
3
)
1
(
2
)
1
(
2
)
1
0
(
1
7
)
8
5
(
2
)
O
N
U
1
6
6
2
8
1
5
/
8
7
/
6
4
6
3
(
3
8
)
2
(
1
)
3
3
(
2
0
)
8
7
(
2
)
T
a
w
e
e
m
o
n
k
o
n
g
s
a
p
e
t
a
l
.
[
1
3
]
C
R
3
1
2
6
Y
e
s
O
p
e
n
1
6
/
1
5
1
8
L
G
/
1
3
H
G
S
D
9
(
2
9
)
2
(
6
)
0
(
0
)
3
(
1
0
)
8
6
(
2
)
O
N
U
2
9
2
8
1
3
/
1
6
1
0
L
G
/
1
9
H
G
1
3
(
4
5
)
1
(
3
)
2
(
7
)
9
3
(
2
)
C
h
u
n
g
e
t
a
l
.
[
1
4
]
H
A
T
3
9
4
8
N
o
O
p
e
n
1
8
/
2
1
1
/
2
2
/
1
6
S
D
1
7
(
4
4
)
1
(
3
)
0
(
0
)
6
(
1
5
)
9
0
(
5
)
O
N
U
3
6
6
0
1
7
/
1
9
1
/
2
0
/
1
5
1
3
(
3
6
)
3
(
8
)
4
(
1
1
)
8
6
(
5
)
R
a
m
a
n
e
t
a
l
.
[
1
5
]
H
A
T
3
8
3
2
Y
e
s
O
p
e
n
(
3
0
)
,
2
7
/
9
2
3
L
G
/
1
5
H
G
N
o
1
1
(
2
9
)
1
(
3
)
0
(
0
)
2
(
6
)
8
1
(
5
)
O
N
U
5
2
5
1
T
U
R
U
O
(
8
)
4
1
/
1
1
3
3
L
G
/
1
9
H
G
1
8
(
3
5
)
0
(
0
)
6
(
1
1
)
7
7
(
5
)
W
o
l
f
e
t
a
l
.
[
1
6
]
H
A
T
5
3
2
5
Y
e
s
T
U
R
U
O
(
2
3
)
,
T
V
(
2
2
)
,
O
p
e
n
(
6
)
,
L
S
(
2
)
3
8
/
1
5
1
8
/
9
/
2
6
S
D
(
5
5
)
(
8
)
0
(
0
)
(
1
6
)
8
0
(
3
)
C
a
n
n
o
n
e
t
a
l
.
[
1
7
]
H
A
T
3
4
1
4
N
o
O
p
e
n
1
7
/
1
8
N
L
N
o
8
(
2
4
)
0
(
0
)
0
(
0
)
2
(
6
)
N
L
H
s
u
e
h
e
t
a
l
.
[
2
1
]
H
A
R
6
6
3
8
N
o
O
p
e
n
3
5
/
3
1
1
/
2
5
/
3
8
N
o
1
3
(
2
0
)
2
(
3
)
0
(
0
)
6
(
9
)
8
0
(
5
)
O
N
U
7
7
5
4
4
3
/
3
3
3
/
3
9
/
3
4
1
9
(
2
5
)
2
(
3
)
1
2
(
1
6
)
7
5
(
5
)
C
h
u
n
g
e
t
a
l
.
[
1
8
]
H
A
R
2
5
3
2
N
o
O
p
e
n
1
3
/
1
2
1
/
1
3
/
1
1
N
o
9
(
3
6
)
3
(
1
2
)
0
(
0
)
2
(
8
)
9
2
(
3
)
O
N
U
4
1
6
2
1
8
/
2
3
1
/
2
3
/
1
7
1
3
(
3
2
)
3
(
7
)
5
(
1
2
)
9
2
(
3
)
N
a
k
a
s
h
i
m
a
e
t
a
l
.
[
1
9
]
H
A
R
3
5
2
3
Y
e
s
O
p
e
n
2
2
≤
T
2
,
1
3
T
3
1
7
≤
G
2
,
1
8
G
3
N
o
1
2
(
3
4
)
1
(
3
)
0
(
0
)
3
(
9
)
8
9
(
2
)
O
N
U
3
8
5
6
2
6
≤
T
2
,
1
1
T
3
2
4
≤
G
2
,
1
3
G
3
2
1
(
5
5
)
1
(
3
)
2
(
5
)
9
1
(
2
)Advances in Urology 5
Table 3: Port-site metastasis following LNU. CR, conventional retroperitoneal; CT, conventional transperitoneal; HAT, hand-assisted
transperitoneal; LNU, laparoscopic nephroureterectomy; NL, not listed; TCC, transitional cell carcinoma; TURBT, transurethral resection
of bladder tumor.
Author Surgery Stage Retrieval bag Metastases location Time to metastasis (mo) Comments
Ahmed et al. [23] CT pT3 No Widespread 8
B a r r e t te ta l .[ 24] CT pT1 No Widespread NL
Otani et al. [25]C T p T 3Y e s T r o c a r 3 Bag torn; preoperative diagnosis of
TCC not known
Ong et al. [26]C R p T 1 Y e s T r o c a r 1 2 Stent perforation in proximal
ureter noted at time of LNU
Chueh et al. [27]H A T p T 2 N L T r o c a r 8
Bilateral LNU and TURBT
performed in renal transplant
patient
Micali et al. [28]C T p T 3Y e s N L 3
Micali et al. [28]C R p T 3Y e s N L 1 5
Micali et al. [28] HAT pT3 Yes NL 3
Micali et al. [28]C R p T 1N o T r o c a r 3 Preoperative diagnosis of TCC not
known
Micali et al. [28]C R p T 1Y e s T r o c a r N L Preoperative diagnosis of TCC not
known
Micali et al. [28]C R p T 2Y e s T r o c a r N L Preoperative diagnosis of TCC not
known
Micali et al. [28] CR NL Yes Trocar NL Preoperative diagnosis of TCC not
known
Matsui et al. [29] CR pT3 No Trocar 6 Squamous cell carcinoma
Naderi et al. [30]C T p T 2 N oTrocar, subcostal
wound 3
Required conversion to open
surgery secondary to renal vein
bleeding
Manabe et al. [20] CR NL NL Widespread NL
Urine extravasation secondary to
urinary tract obstruction noted
preop
Schatteman et al. [9] CT pT4 No Widespread 5 Preoperative diagnosis of TCC not
known
Schatteman et al. [9] CT pT3 No Widespread 8 Preoperative diagnosis of TCC not
known
Schatteman et al. [9] CT pT1 Yes Widespread 11
is associated with a steep learning curve and long procedural
time [42].
Laparoscopic stapling of the distal ureter and bladder
cuﬀ with either cystoscopic unrooﬁng or a pure extraves-
ical approach has also been utilized [43]. This technique,
however, has been associated with the potential risk of stone
formation [44] or viable tumor cells within the incorporated
staple line [45]. A comparison of laparoscopic stapling (20%
of cohort) with cystoscopic detachment and ligation (60%
of cohort) by Matin and Gill was notable for a positive
surgical margin rate of 25% versus 2.8% [46]. Hattori et al.
reported their experience between laparoscopic stapling and
open bladder cuﬀ excision [44]. They noted a signiﬁcantly
decreased operative time with laparoscopic stapling with no
signiﬁcant diﬀerence in bladder and extravesical recurrence-
free rates and disease-speciﬁc survival at 3-year follow-up.
Tsivian et al. detailed a modiﬁed technique for excising the
periurethral bladder cuﬀ en bloc using a LigaSure Atlas
device instead of a stapler [47]. Similarly, excision via
harmonic scalpel has also been utilized [48]. Division of
the bladder cuﬀ using hemostatic diathermy devices may
addressthepotentialconcernsofviabletumorcellsandstone
formation associated with laparoscopic stapling although
further study is needed.
While there have been no randomized prospective trials
comparing the management of the distal ureter, several
groups have reported their retrospective results with several
diﬀerent approaches. In a large multicenter American and
European study, Abou El Fettouh et al. noted that the
local recurrence rates and the development of metastases
depended on pathologic tumor stage and was irrespective of
bladder cuﬀ approach (open, TURUO, cystoscopic detach-
ment and ligation, laparoscopic stapling) [49]. In a series
of 55 patients undergoing hand-assisted transperitoneal
LNU, Brown et al. noted increased perioperative morbidity
and complications with TURUO. However, higher posi-
tive surgical margins were observed following laparoscopic
stapling (29%) or extravesical harmonic scalpel excision6 Advances in Urology
(10%) as compared to TURUO or open techniques [50].
Additionally, in patients without active or recent lower tract
TCC, concerns exist regarding the increased potential risk
of local recurrence when the cystotomy is not primarily
closed following excision of the ureteral oriﬁce and bladder
neck as with many of the endoscopic approaches. Brown
et al. noted their sole pelvic recurrence occurred in 1 of 7
patients without cystotomy closure, leading the authors to
also advocate routine bladder defect closure [50]. However,
Kurzer et al. reported no local recurrences in 49 patients
treatedwithamodiﬁedTURUOtechniqueandnocystotomy
closure at a median follow-up of 10 months [51].
4. Role of Lymphadenectomy
Given its aggressive nature, the presence of nodal involve-
ment in TCC of the renal pelvis and ureter is a poor
prognostic factor and has shown limited response to adju-
vant therapies [52]. However, the role and utilization of
routine lymph node dissection (LND) in conjunction with
either LNU or ONU is not well established. This contrasts
lower urinary tract TCC in which extended pelvic LND
is well supported in the literature for improved staging
and survival beneﬁts [53]. One reason for the variable
use of LND (Table 2) is that the standard template for
regional lymph node involvement in upper tract TCC has
not been well delineated. In a recent review of 42 of 181
patients with upper tract TCC metastases, Kondo et al. noted
that the location of lymph node metastases depended on
the laterality and level of the primary tumor [54]. Based
on their ﬁndings, the authors advocated a relatively wide
LND template, particularly on the right side to include
the paracaval, retrocaval, and interaortocaval nodes. In a
follow-up study, the authors noted an improved cancer-
speciﬁc survival in patients with advanced disease (stage
pT3 or higher) undergoing LND although no diﬀerence
was noted when all pathologic stages were considered [55].
Brausi et al. similarly reported an improved disease-speciﬁc
survival beneﬁt in patients treated with ONU and LND
(81.6%) as compared to ONU alone (44.8%) [56]. However,
the retrospective study may have been inﬂuenced by a
potentialbiasinpatientselectionforLND[57].Additionally,
regardless of the beneﬁts of LND, concerns remain regarding
the technical challenge of laparoscopic lymphadenectomy.
Hattori et al. reported a signiﬁcantly decreased number
of lymph nodes removed following LNU (8.2–11.6) as
compared to ONU (16.5) [44]. Busby and Matin, however,
reported their experience that removal of an equivalent
numberofnodes couldbe performedwithbothlaparoscopic
and open approaches [58].
5.FutureDevelopments
With the increased popularity in robotic-assisted
laparoscopy in urology, individual case reports and small
case series have recently described robotic-assisted LNU
with either retroperitoneal or transperitoneal approaches
[59–62]. The improved dexterity, precision, and control
of robotic assistance may better facilitate handling of the
distal ureter and bladder cuﬀ [60]. However, concerns with
cost and the potential need for patient repositioning and
robot redocking may inﬂuence the widespread utilization of
robotics in treating upper tract TCC.
6. Conclusions
Following the increased popularity of laparoscopy in uro-
logic surgery, LNU has become a common treatment for
TCC of the renal pelvis and ureter with decreased periopera-
tive morbidity, shorter hospitalization, as well as comparable
o n c o l o g i co u t c o m e sa n ds u r v i v a lr a t e sa sw i t hO N U .T h e
optimal technique for mobilization of the kidney and
proximal ureter, as well as excision of the distal ureter and
bladder cuﬀ, is still evolving and largely based on surgeon
preference. The classic open approach for distal ureter
removal is most comparable to the established principles
of open oncologic surgery and simultaneously allows for
intact en bloc specimen removal. Regardless of technique
used, minimal disruption of the urinary tract should be
maintained to decrease the risk of recurrences and port-
site metastases. The role of routine lymphadenectomy and
the utilization of robotic assistance in upper urinary tract
TCC are still to be determined. Long-term studies with
prospective, randomized trials are necessary to fully evaluate
the outcomes of LNU in the management of this aggressive
disease.
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